Lv53
1548 积分 2025-10-24 加入
Re-evaluating antibody–drug conjugate linker stability: assessment, interpretation, and clinical translation
10天前
已完结
High amounts of circulating interleukin (IL)‐6 in the form of monomeric immune complexes during anti‐IL‐6 therapy. Towards a new methodology for measuring overall cytokine production in human in vivo
20天前
已完结
Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Gerilimzumab (GB224), a recombinant humanized interleukin-6 monoclonal antibody, in healthy Chinese adults: A randomized controlled dose-escalation study
20天前
已完结
When more target antigen expression is less
5个月前
已完结
Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial
7个月前
已完结
Comparative assessment of immunogenicity and safety of recombinant influenza vaccine in children, adolescents, and adults: results from a phase 3, immunobridging, open-label, non-randomised study
7个月前
已完结
Pharmacokinetics and absolute bioavailability of mepolizumab following administration at subcutaneous and intramuscular sites
7个月前
已完结
Impact of injection sites on clinical pharmacokinetics of subcutaneously administered peptides and proteins
7个月前
已完结
Preclinical Characterization of AFM26, a Novel B Cell Maturation Antigen (BCMA)-Directed Tetravalent Bispecific Antibody for High Affinity Retargeting of NK Cells Against Myeloma
8个月前
已关闭
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
8个月前
已完结